212 profiles TRACKED
Profiles updated weekly
Q3 EXIT REPORT IN PROGRESS
The Business of Life Science Innovation · Powered by Women
Co-Founder & CBO·Malcova·Newark, CA
Primary Bioscience is betting that single-molecule protein sequencing — not genomics — is the key to making multi-cancer early detection a clinical reality. CEO Stacy Anderson is building the hardware to prove it. The cancer diagnostics industry has spent the better part of a decade chasing the liquid biopsy dream…
The Exit IndeX
across 27 women-led deals in Q2, with every comparable you need before a term sheet.
For years, the industry underpriced rare disease, undervalued underserved patients, and treated Chinese biotech as a discount aisle. This week, on three separate fronts, the market is catching up. This week the FDA moved to make gene therapy development faster…
Servier’s willingness to put $1.55 billion on the table before…
The CGT guidance lands at an unusual moment. CBER’s acting…
In Her Own Words
When I testified before the Senate committee last spring, I realized the gap between how…
October
Year in Review · NYC Milestones
